Adjuvant therapy for colon cancer: genes, genes... and the patient in the center

Although molecular subtype-based stratification and genomic signatures of increasing complexity are becoming a new strategy to guide therapeutic decisions in stage II/III colon cancer, several prognostic factors that can be easily obtained from FFPE specimens should be considered in order to create combined models that better define individual patients needs

from Cancer via ola Kala on Inoreader https://ift.tt/2HPPwPm
via IFTTT